Targeting Specific Patient Populations for Distinct Oral Dosing Formulation Challenges – Flexible Technology is Key

Review of the key trends in regulatory guidance driving patient-centric drug development
Key requirements for oral solid patient-centric product
Insights into the evidence of patient-centric formulation for the pediatric populations
Formulation approaches and technology platforms available for meeting target product profiles factoring in clinical targets, special populations and weight based dosing
Formulation and technology considerations for ensuring viable and scalable manufacturing for specialized dosage formats.
Case studies demonstrating technology and formulation approaches and rationale for meeting target product profiles with two different problem statements